buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories, NDC 68001-264-03
Published September 21, 2016 · Recall initiated: August 4, 2016
Summary
FDA records drug Class III recall D-1501-2016, published September 21, 2016 and initiated August 4, 2016. Recalling firm: Amerisource Health Services; Status: Terminated; Reported quantity: 2626 bottles; Lot: Lot #: MS1509, Exp 12/17. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed dissolution specifications - the out of specification result for dissolution was identified during 3 month stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Amerisource Health Services
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: MS1509, Exp 12/17
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAParoxetine Tablets, USP, 30mg, 100 tablets (10 x 10) , Rx Only, Distributed by: American Health Packaging,November 29, 2017
- FDAEnalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only. Packaged and Distributed by: AmericanNovember 22, 2017
- FDAGlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDCMarch 22, 2017
- FDACycloSPORINE Capsules, USP, 100 mg, 30 count (5x6) blister cartons, Rx only, Distributed by American HealthMarch 8, 2017
- FDAPantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle, Manufactured forSeptember 21, 2016
- FDAULTIMATE NUTRITION AMINO GOLD CAPSULES SUPER WHEY FORMULA Dietary Supplement, 1000 mg, 250 tablets; UPC: 0September 21, 2016
Questions about this recall
Was buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories, NDC 68001-264-03 recalled?
Yes. FDA published recall D-1501-2016 on September 21, 2016. Reported hazard: Failed dissolution specifications - the out of specification result for dissolution was identified during 3 month stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter